Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 14, 2024Open Access

Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as an antimalarial strategy

View Full Paper
Ask AI
Bookmark
Share

Authors

DCDarren J. CreekCGCarlo GiannangeloMCMatthew Challis

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Creek et al. (2024) studied this question.

synapsesocial.com/papers/68e64c3ab6db6435875dc9dbhttps://doi.org/10.7554/elife.92990.2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as an antimalarial strategy2024 · 8 citations
  2. 2Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as an antimalarial strategy2024
  3. 3Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as an antimalarial strategy2024
  4. 4Aminopeptidase Inhibition in Drug‐Resistant <i>Plasmodium falciparum</i> : Structural, Functional, and Pharmacological Rationale for Targeting PfA‐M1 and PfA‐M172026
  5. 5Using Unbiased Chemical Proteomics Approaches to Explore the Target Landscape of the Resistance Refractory 7-Azaindole MMV022224 in <i> <i>Plasmodium falciparum</i> </i>2026